Reports for ABBVIE CORPORATION

Company Name

ABBVIE CORPORATION

Totals

Shortage reports

111

Actual shortage: 3 (3%)
Anticipated shortage: 0 (0%)
Avoided shortage: 5 (5%)
Resolved: 103 (93%)

Discontinuation Reports

9

To be discontinued: 0 (0%)
Discontinued: 8 (89%)
Reversed: 1 (11%)

Late reports

3 (3%)

Overdue reports

2 (67%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ALPHAGAN P 0.15% SOLUTION Resolved 2023-08-14 2023-11-28 201805
SURVANTA 25MG SUSPENSION Avoided shortage 2023-10-12 2023-12-01 206918
SURVANTA 25MG SUSPENSION Avoided shortage 2023-10-12 2023-12-01 206915
ZYMAR 0.3% SOLUTION Resolved 2023-11-14 2023-12-07 210159
VIIBRYD 20MG TABLET Resolved 2023-12-07 2023-12-08 212769
ALPHAGAN P 0.15% SOLUTION Resolved 2023-08-14 2023-12-14 201801
VIIBRYD 10MG TABLET Resolved 2023-12-07 2024-01-16 212766
PRED FORTE 1% DROPS DROPS Resolved 2022-10-04 2024-01-30 171004
BYSTOLIC 5MG TABLET Resolved 2023-05-17 2024-02-06 192664
OCUFLOX 0.3% SOLUTION Actual shortage 2024-01-29 2024-03-25 217532
SURVANTA 25MG SUSPENSION Actual shortage 2024-04-24 2024-05-01 226027

Showing 101 to 111 of 111

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
MODERIBA 600MG TABLET Discontinued 2017-11-20 2018-05-07 29835
TECHNIVIE 12.5MG 75MG 50MG TABLET Discontinued 2017-11-20 2018-05-07 29839
HOLKIRA PAK 50MG 12.5MG 250MG 75MG KIT TABLET Discontinued 2017-11-30 2018-08-30 31302
MODERIBA 400MG TABLET Discontinued 2017-11-30 2018-08-30 31316
MODERIBA 200MG TABLET Discontinued 2017-11-21 2018-08-30 29907
NORVIR 80MG SOLUTION Discontinued 2019-02-20 2019-04-01 76354
HUMIRA 40MG SOLUTION Discontinued 2020-06-29 2020-11-19 119141
LUPRON 5MG SOLUTION Discontinued 2022-01-31 2022-08-17 153896
ALPHAGAN 0.2% LIQUID Reversed 2021-12-09 2023-12-14 150885

Showing 1 to 9 of 9